- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 24, 2025 | 123.75M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 120.47M sh |
| Capex | FY 2024 · Dec 31, 2023 | $51K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$5.86M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $6.07M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $939K |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.98M |
| Current Assets | FY 2024 · Dec 31, 2023 | $6.52M |
| Total Assets | FY 2024 · Dec 31, 2023 | $8.93M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.05 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.05 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $3.5M |
| Net Income | FY 2024 · Dec 31, 2023 | −$6.59M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$6.76M |
| Revenue | FY 2024 · Dec 31, 2023 | $0 |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $10.03M |